TREATMENT WITH CARBONIC ANHYDRASE INHIBITOR ACETAZOLAMIDE AMELIORATES MEMORY IMPAIRMENTS AND NEUROPATHOLOGY IN A TRANSGENIC MODEL OF ALZHEIMER’S DISEASE
Main Authors: | Alessia Costa, Barbara Rani, Fiorella Casamenti, Patrizio Blandina, Claudiu Supuran, Maria Passani, Gustavo Provensi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123009934 |
Similar Items
-
Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders
by: Patrizio Blandina, et al.
Published: (2020-01-01) -
Oxytocin and Fear Memory Extinction: Possible Implications for the Therapy of Fear Disorders?
by: Elisabetta Baldi, et al.
Published: (2021-09-01) -
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
by: Silvia Mussi, et al.
Published: (2022-01-01) -
Short- and Long-Term Social Recognition Memory Are Differentially Modulated by Neuronal Histamine
by: Barbara Rani, et al.
Published: (2021-04-01) -
Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship
by: Dimitrios Tsikas
Published: (2024-12-01)